Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symvess in Extremity Vascular Trauma
NCT07762794Phase 4Not yet recruiting
- Sponsor
- Humacyte
- Start
- Sep 2026
- Primary completion
- Sep 2030
01
Overview
A Phase 4 trial of acellular tissue engineered vessel in Extremity Vascular Trauma, sponsored by Humacyte. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
acellular tissue engineered vessel
03
Conditions
Extremity Vascular Trauma
Beyond the preview
Go deeper on NCT07762794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07762794.